EAHP represents over 29,000 hospital pharmacists across 36 member countries. EAHP represents and develops the hospital pharmacy profession within Europe in order to ensure the continuous improvement of care and outcomes for patients in the hospital setting. This is achieved through science, research, education, practice, as well as sharing best-practice and responsibility with other healthcare professionals.
The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
The EAHP staff supports the Board in executing EAHP’s mission. The Staff assists in financial management, events organisations, policy activities and all EAHP projects. The EAHP staff works closely with EAHP’s members and ensures the effective communication all relevant stakeholders.
The first member countries were Belgium, Britain, Denmark, France, the Federal Republic of Germany and The Netherlands in 1972. EAHP has now 36 EAHP members and 2 Associate Members. EAHP is open to countries members of the Council of Europe and since 2022 to organisations representing the interests of hospital pharmacists from outside the Council of Europe (Associate Membership)
EAHP’s structure is also composed by different standing committes: EAHP Scientific Committee, EAHP Education Executive Committee and the EAHP CTF Steering Committee.
At EAHP, we are committed to transparency in our governance, ethical standards, and funding practices. This section provides open access to our foundational documents, including the EAHP Statutes, Code of Conduct, and Funding Sources. By sharing these resources, we aim to uphold accountability and foster trust with our members, partners, and the public.
Keep up with all EAHP’s events and webinars. Contact the team at info@eahp.eu should you have any questions about upcoming events or activities.
Here you can find all upcoming events organised by EAHP and by all its members and associate members. Do not hesitate to contact the events team at events@eahp.eu should you have any questions about the organisation of these events.
Hospital pharmacists conduct a critical role in the care of patients in hospitals. Learn more about what they do here and in all the pages under Hospital Pharmacy practice and Policy.
Self-Assessment
SILCC
Closed SIGs
EAHP brings together experts from many areas of hospital pharmacy practice providing and highlighting good local sustainable practices as that can be up-scaled and shared with other countries. The EAHP Working Group on Sustainability has the aim of reducing the environmental burden of the hospital pharmacy services.
The European Association of Hospital Pharmacists (EAHP), and its 36 member country platforms are creating a Common Training Framework for the hospital pharmacy education in Europe. The goal of this project is to allow the free movement of hospital pharmacists within the European Union.
The European Association of Hospital Pharmacists (EAHP) and the European Society of Clinical Pharmacy (ESCP) have collaboratively developed the Oath to Society. The Oath to Society is all encompassing and acts as a contract for excellence in providing compassionate patient care, working as part of the healthcare team and advancing the pharmacy profession, and showcasing how clinical and hospital pharmacists work every day
A day created to highlight the importance and to celebrate the work done by hospital pharmacies. This day celebrates all hospital pharmacy teams.
Catch up with EAHP’s press releases
Find all EAHP relevant publication like the EAHP Surveys, annual reports and the history books.
The European Journal of Hospital Pharmacy (EJHP) is the only official journal of the European Association of Hospital Pharmacists (EAHP) and is committed to advancing the science, practice and profession of hospital pharmacy. As the premier communication platform for hospital pharmacists worldwide, EJHP is a major source for continuing education as well as updates on advances in the practice and standard of pharmaceutical care for patients.
When EAHP and Hospital pharmacists appear in the news.
EAHP publishes a monthly EU monitor with updates about the latest EAHP initiatives and information relevant for the hospital pharmacy profession.
Sponsor Channel
The Sponsor Channel is designed to maximise visibility and engagement, allowing sponsors to connect with the hospital pharmacy community and partners in a dynamic and interactive environment. From product demonstrations to networking sessions, the Sponsor Channel offers a range of opportunities for sponsors to showcase their offerings and generate leads in the new EAHP Website.
The EAHP EU Monitor is a regular round up of news relevant to hospital pharmacy in Europe.
You can subscribe to receive the EAHP EU Monitor by email HERE.
The Common Training Framework (CTF) project of the European Association of Hospital Pharmacists (EAHP) has a new milestone to report. Working Group 2 which was tasked with the compilation of supporting evidence published a literature review. This review analysed the impact of educational interventions on health outcome to determine the value that can be created in forming a CTF for hospital pharmacy. The findings of Working Group 2 were published in the online first edition of the European Journal of Hospital Pharmacy (EJHP).
Members of Working Group 2 analysed 9 primary research studies and one literature review which were selected due to their relation to education and impact of pharmacists, medical doctors or nurses on patient outcomes. The literature search was carried out by two teams of researchers to ensure inter-rater reliability at each stage of screening and data extraction. However, the search was limited on the one hand to two databases and restricted on the other hand by the limited number of studies published in the English language.
Almost one-third of the selected studies targeted pharmacists in their research. The importance of a CTF was not specifically discussed. Nonetheless, the review carried out by Working Group 2 showed that higher education levels of healthcare professionals improve patient outcomes. Since, higher degrees or extended training positively affected patient outcomes, including mortality rates, it was concluded by Working Group 2 that further hospital pharmacy education could significantly impact the professional status and services reimbursement.
The literature review also touched upon labour mobility, one of the EU’s four freedoms. Currently, hospital pharmacists have difficulties to use this freedom due to the different systems that are employed by the national bodies responsible for the recognition of professional qualifications. A CTF could not only improve labour mobility of hospital pharmacist, but also increase the prospect of cooperation in specialisation education provision between different countries, always with the aim of providing the same standards of care to all patients. As the foundation stone for ensuring the best use of medicines by patients in hospitals, a CTF for hospital pharmacy could become the benchmark for all European countries to strive for.
EAHP would like to thank both the chair of Working Group 2, Roberto Frontini, and its individual members (Cornelia Vetter Kerkhoff, Eduardo Echarri, Ian Bates, Jos Kosterink, Jose Manuel Martinez Sesmero, László Horváth, Lorna Marie West, Nenad Miljkovic and Stephanie Belaiche) for their contribution to the CTF project.
The literature review is available HERE
In preparation of the 10th anniversary of the European Antibiotic Awareness Day (EAAD) the European Centre for Diseases Prevention and Control (ECDC) redesigned its EAAD website and launched a new toolkit for hospital professionals. The EAAD – which takes place every year on 18th November – will focus on healthcare professionals and their efforts to keep antibiotics working.
The new EAAD website is a more dynamic and easy-to-access hub for resources to raise awareness about prudent use of antibiotics and about antibiotic resistance. It features a full set of informative resources aimed at the general public and at healthcare professionals, including factsheets, videos and infographics. A set of communication tools that can be used to raise awareness about prudent use of antibiotics is available for free, together with a guidance document on how to develop a social media campaign on the topic. Stories of patients who battled infections by antibiotic-resistant bacteria and an overview of awareness campaigns on prudent antibiotic use and antibiotic resistance developed throughout Europe are also on display.
To further guide professionals in hospitals and other healthcare settings, the ECDC also released a new toolkit which contains materials to help these professionals influence the use of antibiotics in their work environment. It includes factsheets, infographics, posters and leaflets that can be adapted. The toolkit addresses healthcare professionals such as prescribers, nurses and also hospital pharmacists by highlighting a series of actions that should be taken to prevent the spread of resistant bacteria as well as the misuse of antibiotics.
Hospital pharmacists are encouraged by ECDC to keep antibiotics working through
By covering a number of professionals working at hospitals and other healthcare settings the new toolkit aims at creating a sense of individual responsibility in tackling antibiotic resistance and at empowering professionals to take action.
To mark the 10th anniversary of the EAAD, ECDC has also launched a social media call-to-action initiative called #KeepAntibioticsWorking. This initiative prompts all EAAD stakeholders, professionals and members of the general public to share a message on social media to explain what they are doing to ensure antibiotics remain effective. On 15th November, the new toolkit will be launched officially during the world antibiotic awareness week. EAHP will participate in the launch event.
Key messages for hospital pharmacists HERE
Communication toolkit for healthcare professionals HERE
Information on social media initiative HERE
The European Medicines Agency (EMA) and the European Commission’s Directorate-General for Health and Food Safety (DG SANTE) have adopted a joint action plan to foster the development of advanced therapy medicinal products (ATMPs).
ATPMs are medical products for human use based on genes or cells that offer potentially ground-breaking opportunities for the treatment of injury and disease, particularly in cases of severe, untreatable or chronic diseases which do not respond adequately to conventional treatments. They can be categorised into four main groups: gene therapy medicinal products, somatic cell therapy medicinal products, tissue engineered medicines and combined ATMPs.
These products are governed by Regulation 1394/2007 on advanced therapy medicinal products which mandates that a marketing authorisation must be obtained prior to the marketing of ATMPs. The evaluation of these products is led by the Committee for Advanced Therapies – a specialised committee within EMA. The Regulation also empowers Member States to permit the use of advanced therapies that have not been authorised by the Commission under certain conditions (so-called “hospital exemption”). The joint new action plan does not foresee changes to this regulatory framework, instead it identifies initiatives designed to optimise the regulatory environment. These include a European Commission guideline on good manufacturing practice for ATMPs; the initiation of dialogue with national competent authorities; new EMA scientific guidelines on ATMPs; as well as awareness raising.
Joint action plan available HERE
EJHP: Identification and prioritisation of risks in a hospital pharmacy using healthcare failure mode and effect analysisThe online first edition of the European Journal of Hospital Pharmacy (EJHP) has published an original article focusing on the identification and prioritisation of risks in a hospital pharmacy. Risks were identified by failure mode and effect analysis and prioritised according to their risk priority index (RPI) and criticality.
More HERE
————————————————————–
Consultations
EMA – Reflection paper on the use of extrapolation in the development of medicines for paediatrics
The reflection paper aims to provide guidance on the main regulatory requirements that are expected to be met for the evaluation of extrapolation approaches in development of medicines for children. However, indicating preferences for the use of particular quantitative methods to address specific objectives of paediatric development is not within the scope of this document. The principles outlined should encourage further exploration of potentially suitable methods for specific situations, and choice of strategies should be justified.
Deadline – 14th January
More information HERE
EMA – Reflection paper on the pharmaceutical development of medicines for use in the older population
The reflection paper describes aspects that medicines developers may consider when designing medicines for older people, such as selecting appropriate routes of administration and dosage forms, dosing frequency, excipients, container closure systems, devices and technologies, and user instructions in the product information. It is intended to communicate the current status of discussions on the pharmaceutical development of medicines that may be used in the older population.
Deadline – 31st January 2018
More information HERE
Upcoming events
22nd November – Game Changers for better and affordable medicines for Europe – Brussels, Belgium
The 2017 Universal Access and Affordable Medicines Forum of the European Public Health Alliance (EPHA) organised under the auspices of the Bulgarian Health Ministry aims at setting out a positive agenda of actionable policy recommendations to be implemented at the European and national level. The one-day event will provide participants with stimulating and lively discussions on the hottest topics in pharmaceuticals.
